Tanibirumab (TTAC-0001): A Fully Human Monoclonal Antibody Targets Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2)

被引:29
|
作者
Lee, Sang Hoon [1 ]
机构
[1] PharmAbcine, Taejon 305811, South Korea
关键词
TUMOR ANGIOGENESIS; THERAPY; DISEASE;
D O I
10.1007/s12272-011-0821-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Vascular endothelial growth factor (VEGF) binds to its receptor (VEGFR) and stimulates angiogenesis, an important step in tumor growth and metastasis. Several anticancer therapies targeting VEGFR with small molecules and antibody have been currently studied in preclinical and clinical studies. This article provides a review of human monoclonal antibody tanibirumab (TTAC-0001), which specifically binds VEGFR-2 and is currently being developed in preclinical stage by PharmAbcine (Daejon, Korea).
引用
收藏
页码:1223 / 1226
页数:4
相关论文
共 50 条
  • [31] Single-molecule study of the dynamic organization of Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) on the endothelial cell surface.
    Da Rocha-Azevedo, B.
    Vega, A.
    Dasgupta, A.
    Lee, S.
    Kim, T.
    Kittisopikul, M.
    de Oliveira, L.
    Jaqaman, K.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [32] VASCULAR ENDOTHELIAL GROWTH FACTOR AND HIS RECEPTORS, VEGFR-1 AND VEGFR-2, IN AIRWAYS OF PATIENTS WITH NSCLC
    Charpidou, Andriani G.
    Gkiozos, Ioannis
    Eleftheraki, Anastasia
    Gratsias, Manolis
    Fevranoglou, Christina
    Polyzos, Aris
    Syrigos, Kostas N.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S945 - S946
  • [33] Calcium enhance mRNA expression of vascular endothelial growth factor receptor (VEGFR) 1, VEGFR-2 and VEGFR-3, but not neuropilins on epidermal keratinocytes
    Man, X.
    Zheng, M.
    Yang, X.
    Cai, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 2 - 2
  • [34] Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
    Smith, Neil R.
    Baker, Dawn
    James, Neil H.
    Ratcliffe, Kirsty
    Jenkins, Martin
    Ashton, Susan E.
    Sproat, Graham
    Swann, Ruth
    Gray, Neil
    Ryan, Anderson
    Juergensmeier, Juliane M.
    Womack, Chris
    CLINICAL CANCER RESEARCH, 2010, 16 (14) : 3548 - 3561
  • [35] Vascular endothelial growth factor from Trimeresurus jerdonii venom specifically binds to VEGFR-2
    Zhong, Shurong
    Wu, Jianbo
    Cui, Yunpeng
    Li, Rui
    Zhu, Shaowen
    Rong, Mingqiang
    Lu, Qiumin
    Lai, Ren
    BIOCHIMIE, 2015, 116 : 1 - 7
  • [36] Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling
    Wittig, Christine
    Scheuer, Claudia
    Parakenings, Julia
    Menger, Michael D.
    Laschke, Matthias W.
    PLOS ONE, 2015, 10 (07):
  • [37] Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors
    Farkkila, Anniina
    Anttonen, Mikko
    Pociuviene, Jurate
    Leminen, Arto
    Butzow, Ralf
    Heikinheimo, Markku
    Unkila-Kallio, Leila
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (01) : 115 - 122
  • [38] Utilization of Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2)/Lac-Z mice to elucidate the role of Vascular Endothelial Growth Factor (VEGF) on vascular development during gonadal morphogenesis.
    Baltes, M.
    Bott, R.
    Clopton, D.
    Cupp, A.
    JOURNAL OF ANIMAL SCIENCE, 2006, 84 : 102 - 102
  • [39] Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the Mouse
    Douglas, Nataki C.
    Tang, Hongyan
    Gomez, Raul
    Pytowski, Bronislaw
    Hicklin, Daniel J.
    Sauer, Christopher M.
    Kitajewski, Jan
    Sauer, Mark V.
    Zimmermann, Ralf C.
    ENDOCRINOLOGY, 2009, 150 (08) : 3845 - 3854
  • [40] Selective inhibition of vascular endothelial growth factor receptor-2 (VEGXR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF
    Endo, A
    Fukuhara, S
    Masuda, M
    Ohmori, T
    Mochizuki, N
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2003, 23 (2-3) : 239 - 254